These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17204028)

  • 1. Tumour budding in colorectal carcinoma.
    Prall F
    Histopathology; 2007 Jan; 50(1):151-62. PubMed ID: 17204028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
    Vincan E; Brabletz T; Faux MC; Ramsay RG
    Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent pathology related advances in colorectal adenocarcinomas.
    Goldstein NS
    Eur J Surg Oncol; 2001 Aug; 27(5):446-50. PubMed ID: 11504513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-up.
    Wöhlke M; Schiffmann L; Prall F
    Histopathology; 2011 Nov; 59(5):857-66. PubMed ID: 22092397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumour-cell dissociation as a prognostic marker in colorectal cancer].
    Klarskov L; Engel UH; Mogensen AM; Jensen HL; Holck S
    Ugeskr Laeger; 2009 Sep; 171(39):2812-7. PubMed ID: 19811751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?
    Thompson EW; Newgreen DF; Tarin D
    Cancer Res; 2005 Jul; 65(14):5991-5; discussion 5995. PubMed ID: 16024595
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the histological characteristics linked to local tumour invasion in colorectal carcinomas.
    Rubio CA
    Anticancer Res; 2003; 23(4):3555-60. PubMed ID: 12926106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma in inflammatory colorectal disease. Histological features pertinent to local tumour progression.
    Rubio CA
    Anticancer Res; 2003; 23(5b):4313-8. PubMed ID: 14666644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
    Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
    J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department.
    Chan NG; Duggal A; Weir MM; Driman DK
    Can J Surg; 2008 Aug; 51(4):284-8. PubMed ID: 18815652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition.
    Stewart CJ; Little L
    Histopathology; 2009 Jul; 55(1):91-101. PubMed ID: 19614771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tumour budding at the front of invasion and recurrence of rectal carcinoma.
    Guzińska-Ustymowicz K
    Anticancer Res; 2005; 25(2B):1269-72. PubMed ID: 15865077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology.
    Jass JR; O'Brien J; Riddell RH; Snover DC;
    Am J Clin Pathol; 2008 Jan; 129(1):13-23. PubMed ID: 18089485
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
    Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
    Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
    Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
    Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.
    Wang LM; Kevans D; Mulcahy H; O'Sullivan J; Fennelly D; Hyland J; O'Donoghue D; Sheahan K
    Am J Surg Pathol; 2009 Jan; 33(1):134-41. PubMed ID: 18971777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal to epithelial transition in development and disease.
    Chaffer CL; Thompson EW; Williams ED
    Cells Tissues Organs; 2007; 185(1-3):7-19. PubMed ID: 17587803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tumor budding in gastrointestinal tumors.
    Märkl B; Arnholdt HM
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1521-33. PubMed ID: 21999126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.